Abstract:Objective To study the influence of visfatin on the development of atherosclerosis(AS),and to explore the possible anti-atherosclerotic mechanism of Tanshinone ⅡA sodium in ApoE gene knock-out mice. Methods C57BL/6J genetic background ApoE-/- mice were randomly divided into model group,high-dose Tanshinone ⅡA group(20 mg·kg-1),low-dose TanshinoneⅡA group(10 mg·kg-1),and Simvastatin group(5 mg·kg-1),8 mice in each group. Eight wild-type male C57BL/6J mice were used for blank control. ApoE-/- mice were fed with high fat diet for 14 weeks to induce AS. At the end of the experiment,the mice were executed. The aortic plaque was observed after HE dyeing,and the ratio of plaque area to arterial lumina area was calculated. The serum lipid contents were observed with enzyme method. Serum inflammation cytokines such as high-sensitivity C-reactive protein (hs-CRP),tumor necrosis factor alpha(TNF-α)and matrix metalloproteinase -9(MMP-9)were detected by enzyme-linked immunosorbent assay (ELISA). Total protein was extracted from aortic tissue for detecting the expression of Visfatin by western blotting. Results (1)Blank control group showed no distinctive changes of atherosclerosis,model group had distinctive increase of aortic intima thickness and atherosclerotic plaque formation. Model group also had high serum levels of total cholesterol(TC),triglyceride(TG)and low-density lipoprotcin(LDL),and high inflammatory cytokines of hs-CRP, TNF-α,MMP-9,as well as high visfatin expression in aorta tissue. However,high-density lipoprotein(HDL)in the model group was lower than the black control group(P < 0.05).(2)Compared with the model group,the ratio of plaque area to arterial lumina area was reduced, the serum levels of TC, TG, and LDL-C were decreased(P < 0.05), HDL-C was increased(P < 0.05), and inflammatory cytokines of hs-CRP, TNF-α, MMP-9 as well as visfatin expression were lowered in high- and low-dose TanshinoneⅡA groups and Simvastatin group.(3)TanshinoneⅡA could reduce plaque area,improve serum lipid,suppress inflammation and visfatin expression in significant dose-dependent manner. The differences in reducing plaque area and improving serum lipids between high-dose TanshinoneⅡA group and Simvastatin group were insignificant, but were significant in lowering hs-CRP, TNF-α, MMP-9 as well as visfatin expression.(4)Positive correlation was shown between visfatin expression and the levels of inflammatory cytokines of hs-CRP,TNF-α and MMP-9. Conclusion Visfatin plays a role in the development of atherosclerosis, the possible mechanism may be associated with inflammatory cytokines. TanshinoneⅡA could inhibit the development of atherosclerosis by regulating serum lipids,suppressing inflammation factors of hs-CRP,TNF-α and MMP-9,and down-regulating the expression of visfatin.

HIF-1α Mediates Visfatin-Induced CTGF Expression in Vascular Endothelial Cells

Visfatin: an Adipokine Activator of Rat Hepatic Stellate Cells

Effects of Visfatin on Proliferation and Collagen Synthesis in Rat Cardiac Fibroblasts

Effect of visfatin on angiogenic function of endothelial progenitor cells

Effect of Visfatin on the Expression of Basic Fibroblast Growth Factor in Rat Hepatic Stellate Cells

Involvement of Dimethylarginine Dimethylaminohydrolase‐2 in Visfatin‐enhanced Angiogenic Function of Endothelial Cells

High Glucose Upregulates Connective Tissue Growth Factor Expression in Human Vascular Smooth Muscle Cells

Visfatin Promotes Angiogenesis of RF/6A Cells Through Upregulation of VEGF/VEGFR-2 under High-Glucose Conditions

[Effect of Hypoxia on the Activation and Visfatin Expression in Rat Hepatic Stellate Cells].

Perivascular Adipose Tissue-Derived Visfatin is a Vascular Smooth Muscle Cell Growth Factor: Role of Nicotinamide Mononucleotide

Toll‐like Receptor 4 Mediates Pro‐inflammatory Effects of Visfatin on Endothelial Cells

Visfatin Inhibits Colon Cancer Cell Apoptosis and Decreases Chemosensitivity to 5‑FU by Promoting the SDF‑1/CXCR4/Akt Axis.

Effects and mechanism of visfatin on MMP-9 in macrophages

Role of Visfatin in Development of Atherosclerosis and Intervention of Tanshinone Ⅱ A in ApoE Gene Knock-out Mice

Visfatin is a multifaceted molecule that exerts regulation effects on inflammation and apoptosis in RAW264.7 cells and mice immune organs

Effects of Transforming Growth Factor β1 on the Expression of Integrin β3 and the Activity of Focal Adhesion Kinase on Human Vascular E ndothelial Cell

Glucagon-like Peptide-1 Upregulates Visfatin Expression in 3T3-L1 Adipocytes

CTGF regulated by ATF6 inhibits vascular endothelial inflammation and reduces hepatic ischemia-reperfusion injury

Study on Visfatin-Induced Inflammation and Necroptosis Via LOX-1 in Human Umbilical Vein Endothelial Cells

Up-regulation of Visfatin Expression in Subjects with Hyperthyroidism and Hypothyroidism is Partially Relevant to a Nonlinear Regulation Mechanism Between Visfatin and Tri-Iodothyronine with Various Concentrations.

Visfatin/PBEF/Nampt Induces EMMPRIN and MMP-9 Production in Macrophages Via the NAMPT-MAPK (p38, ERK1/2)-NF-κB Signaling Pathway.